Category: Open Ended Investment Company
Objective The objective of the Fund is to seek capital growth. Investment Policy To invest in equity and equity related securities from a broad range of locations and sectors, both in developed and emerging markets. To have a concentrated portfolio, generally comprising 25 – 35 listed stocks, principally in equities, based on detailed research by the Investment Manager. Essential features of the Fund The Fund is actively managed without reference to a benchmark index. The Fund's performance will be compared against the IA Global Sector. The IA Global Sector is a group of UK funds in the same sector grouped together by the UK Investment Association (the trade body that represents UK investment managers). The Fund can invest in any market or geographic sector with no particular sector or style bias. Aggregate investment in emerging markets shall not exceed 20% of NAV. You can buy and sell shares in the Fund every Business day. Income from the Fund will be added to the value of your investment. The Fund may invest in other open-ended collective investment schemes, to a maximum of 10% of the Fund's overall NAV. The Fund may invest in money market funds or instruments for liquidity or defensive purposes. Currency hedging arrangements may be used to reduce the risk of currency movements in the value of securities held by the Fund which are not denominated in US Dollar. The Fund can be leveraged up to 100% of its NAV through use of financial derivative instruments (FDI). Investment by the Fund in Russia shall not exceed 10% of the Fund’s NAV. The base currency of the Fund is US Dollars.
Closing Price 09/04/2021 | 11.47 |
Morningstar category | Global Large-Cap Blend Equity |
Currency | USD |
Distribution status | Accumulating |
ISIN | IE00BJM0B746 |
Inception Date | 25/09/2020 |
Minimum initial amount | 100.00 USD |
Entry fee | None |
Custody fee | None |
Exit fee | None |
Ongoing charge | 2.00% of which 0.50% is paid to MeDirect |
Address | Blue Whale Capital LLP (Link) 22-23 Old Burlington Street, London W1S 2JJ United Kingdom |
Manager Name | Stephen Yiu |
Manager Start Date | 25/09/2020 |
Website | www.bluewhale.co.uk |
Total Net Assets (mil) | 88.07 USD (31/03/2021) |
UCITS | Yes |
Administrator | Link Fund Administrators (Ireland) Ltd |
% Long | % Short | % Net Assets | |
Stock | 95.39% | 0.00% | 95.39% |
Bond | 0.00% | 0.00% | 0.00% |
Cash | 4.61% | 0.00% | 4.61% |
Other | 0.00% | 0.00% | 0.00% |
Risk Measurement | 1 Year | 3 Years | 5 Years |
Standard Deviation | - | - | - |
Sharpe Ratio | - | - | - |
Sortino Ratio | - | - | - |
Positive Months | - | - | - |
Negative Months | - | - | - |
Worst Month | - | - | - |
Region | % |
United States | 69.09 |
Eurozone | 20.03 |
Europe - ex Euro | 2.85 |
United Kingdom | 1.98 |
Australasia | 1.44 |
Sector | % of Equity |
Technology | 45.15 |
Financial Services | 14.61 |
Healthcare | 14.12 |
Communication Services | 7.60 |
Consumer Defensive | 7.41 |
Consumer Cyclical | 5.06 |
Industrials | 1.44 |
Holding | Sector | Country | % of Assets |
Adobe Inc | Technology | United States | 7.57 |
Microsoft Corp | Technology | United States | 7.07 |
Visa Inc Class A | Financial Services | United States | 5.94 |
Autodesk Inc | Technology | United States | 5.56 |
Mastercard Inc A | Financial Services | United States | 5.01 |
Facebook Inc A | Communication Services | United States | 4.54 |
Intuit Inc | Technology | United States | 4.54 |
Dassault Systemes SE | Technology | France | 4.47 |
Stryker Corp | Healthcare | United States | 4.27 |
Boston Scientific Corp | Healthcare | United States | 4.04 |
Ranking | 1 Year | 2 Years | 3 Years | 5 Years |
Top 25% | ||||
Category above the average | ||||
Category below the average | ||||
Bottom 25% |
Large | Size | |||
Mid | ||||
Small | ||||
Value | Blend | Growth | ||
Style |